Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 3939-13-7 | MDL No. : | MFCD03095082 |
Formula : | C6H3FN2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | USIDQCCXMGJOJM-UHFFFAOYSA-N |
M.W : | 122.10 | Pubchem ID : | 2783254 |
Synonyms : |
|
Num. heavy atoms : | 9 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 28.91 |
TPSA : | 36.68 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.33 cm/s |
Log Po/w (iLOGP) : | 1.22 |
Log Po/w (XLOGP3) : | 1.0 |
Log Po/w (WLOGP) : | 1.51 |
Log Po/w (MLOGP) : | 0.22 |
Log Po/w (SILICOS-IT) : | 1.76 |
Consensus Log Po/w : | 1.14 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.72 |
Solubility : | 2.32 mg/ml ; 0.019 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.36 |
Solubility : | 5.34 mg/ml ; 0.0437 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.34 |
Solubility : | 0.554 mg/ml ; 0.00454 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.63 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
69% | With cesium fluoride In dimethyl sulfoxide at 90℃; for 2 h; | General procedure: To a solution of 2,3-dichloropyridine(1.00 g, 6.76 mmol) in DMSO (33.8 ml) was added CsF (2.053 g, 13.51mmol) at room temperature. The mixture was stirred at 110 °C under air for 20h. The mixture was quenched with water at room temperature and extracted withEtOAc. The organic layer was separated, washed with water and brine, dried overNa2SO4 and concentrated in vacuo. The residue waspurified by column chromatography (silica gel, eluted with EtOAc in hexane) togive 3-chloro-2-fluoropyridine (0.639 g, 4.86 mmol, 71.9 percent) as colorlessoil. Thecompound 3B'-8B' were prepared in amanner similar to that described for 2B'. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
64% | With resin bound triphenylphosphine In tetrachloromethane; 1,2-dichloro-ethane for 18 h; Heating / reflux | Preparation 51; 2-Fluoro-nicotinonitrile; Add resin bound triphenylphosphine (4.0 g, 12.0 mmol) to a solution of 2-fluoro- nicotinamide (0.6 g, 4.3 mmol) in dichloroethane (20.0 mL) and carbon tetrachloride (20.0 mL). Reflux for 18 hours, cool to RT, filter, and concentrate the filtrate under vacuum. Purify by flash column on silica gel eluting with 10-60percent EtOAc in hexanes to give the title compound (0.34 g, 64percent). MS (ES) 123.1 (M+l) +. 1H NMR (400 MHz, CHC13) 6 8.46 (m, 1H), 8.09 (m, 1H), 7.37 (m, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
28% | Stage #1: With potassium <i>tert</i>-butylate In N,N-dimethyl-formamide at 20℃; for 0.5 h; Stage #2: at 50℃; for 5 h; |
Synthesis of intermediate VX001: Isoxazolo[5,4-b]pyridin-3-amine 909 mg (8.1 mmol) of KO-t-Bu were added, with vigorous stirring, to a suspension of 668 mg (8.9 mmol) of acethydroxamic acid in DMF (20 ml), and the mixture was stirred for 30 min at RT. 990 mg (8.1 mmol) of 2-fluoro-nicotinonitrile were then added, and stirring was carried out for a further 5 h at 50° C. The mixture was then extracted with EA and the organic phase was dried over Na2SO4, filtered and concentrated in vacuo. CC (hexane/EA 7:3) of the residue yielded 305 mg (2.3 mmol, 28percent) of isoxazolo[5,4-b]pyridin-3-amine. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | With hydrogen In ethanol for 3 h; | Example 9: Synthesis of 3-Aminometliyl-2-fluoropyridine19 20[0098] A round bottom flask was charged with 0.3g (2.46mM) of 3-cyano-2- fluoropyridine (19), which was then diluted in 2OmL EtOH. The solution was flushed with argon, and then while under a blanket of argon, 60mg of 10percent Pd/C (20percent by weight), was added. The system was then sealed by septum and put under vacuum. A hydrogen balloon was then added, and the reaction was stirred for three hours (followed by TLC). The reaction was then put under vacuum again, then exposed to air, and filtered (keeping catalyst wet). The resulting solution was dried and evaporated to give 0.28g (90percent) of the title compound, 3-aminomethyl-2-fluoropyridine (20). |
90% | With hydrogen In ethanol for 3 h; | Example 9 Synthesis of 3-Aminomethyl-2-fluoropyridine A round bottom flask was charged with 0.3 g (2.46 mM) of 3-cyano-2-fluoropyridine (19), which was then diluted in 20 mL EtOH. The solution was flushed with argon, and then while under a blanket of argon, 60 mg of 10percent Pd/C (20percent by weight), was added. The system was then sealed by septum and put under vacuum. A hydrogen balloon was then added, and the reaction was stirred for three hours (followed by TLC). The reaction was then put under vacuum again, then exposed to air, and filtered (keeping catalyst wet). The resulting solution was dried and evaporated to give 0.28 g (90percent) of the title compound, 3-aminomethyl-2-fluoropyridine (20). |
90% | With hydrogen In ethanol for 3 h; | A round bottom flask was charged with 0.3g (2.46mM) of 3-cyano-2- fluoropyridine (19), which was then diluted in 2OmL EtOH. The solution was flushed with argon, and then while under a blanket of argon, 60mg of 10percent Pd/C (20percent by weight), was added. The system was then sealed by septum and put under vacuum. A hydrogen balloon was then added, and the reaction was stirred for three hours (followed by TLC). The reaction was then put under vacuum again, then exposed to air, and filtered (keeping catalyst wet). The resulting solution was dried and evaporated to give 0.28g (90percent) of the title compound, 3-aminomethyl-2-fiuoropyridine (20). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
82% | With hydrogenchloride; hydrogen In methanol; water at 20℃; for 6 h; | Preparation 47; C- (2-Fluoro-pyridin-3-yl)-methylamine hydrochloride; Add concentrated HC1 (0.46 mL) to a suspension 2-fluoro-nicotinonitrile (0.34 g, 2.8 mmol) and 5percent Pd/C (0.5 g) in methanol (10 mL) at RT. Stir suspension under an atmosphere of hydrogen at 1 atm. For 6 hours. Filter reaction mixture and concentrate the filtrate. Add ether to the residue, bubble HC1 gas through the suspension, filter precipitate, and dry to give the title compound (0.37 g, 82percent). MS (ES) 127.1 (M+l) +. lu NMR (400 MHz, DMSO) 8 : 8.65 (brs, 3H), 8.24 (m, 1H), 8.16 (m, 1H), 7.41 (m, 1H), 4.06 (m, 2H). |
[ 1232432-76-6 ]
2-Fluoro-5-methylnicotinonitrile
Similarity: 0.96
[ 1256821-83-6 ]
5-Bromo-2-fluoronicotinonitrile
Similarity: 0.80
[ 870065-73-9 ]
2,5,6-Trifluoronicotinonitrile
Similarity: 0.74
[ 1232432-76-6 ]
2-Fluoro-5-methylnicotinonitrile
Similarity: 0.96
[ 1256821-83-6 ]
5-Bromo-2-fluoronicotinonitrile
Similarity: 0.80
[ 870065-73-9 ]
2,5,6-Trifluoronicotinonitrile
Similarity: 0.74
[ 1232432-76-6 ]
2-Fluoro-5-methylnicotinonitrile
Similarity: 0.96
[ 1256821-83-6 ]
5-Bromo-2-fluoronicotinonitrile
Similarity: 0.80
[ 870065-73-9 ]
2,5,6-Trifluoronicotinonitrile
Similarity: 0.74